Login / Signup

Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy.

Sara HarryssonSandra ElorantaSara EkbergGunilla EnbladPer-Ola AnderssonKristina SonneviMaria LjungqvistBirgitta SanderMats JerkemanKarin E Smedby
Published in: Leukemia & lymphoma (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • cell therapy
  • epstein barr virus
  • stem cells
  • mesenchymal stem cells
  • blood brain barrier
  • acute lymphoblastic leukemia
  • type diabetes
  • metabolic syndrome
  • skeletal muscle
  • hodgkin lymphoma